Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2017 Publisher: Novartis Pharmaceuticals UK Limited, Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR, United Kingdom
CILOXAN 0.3% w/v eye drops, solution.
| Pharmaceutical Form |
|---|
|
Eye drops, solution. A clear and colourless to pale yellow solution. |
Ciprofloxacin 0.3% w/v (as hydrochloride).
Excipients with known effect: One ml of solution contains 0.06mg of benzalkonium chloride.
For a full list of excipients, see Section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Ciprofloxacin |
Ciprofloxacin is a fluoroquinolone antibacterial agent. The bactericidal action of ciprofloxacin results from the inhibition of both type II topoisomerase (DNA-gyrase) and topoisomerase IV, required for bacterial DNA replication, transcription, repair and recombination. |
| List of Excipients |
|---|
|
Benzalkonium chloride |
5 ml Drop-Tainer LDPE bottle and plug with a polystyrene or polypropylene cap.
Novartis Pharmaceuticals UK Limited, Frimley Business Park, Frimley, Camberley, Surrey, GU16 7SR, United Kingdom
PL 00101/0994
23 November 1993 / 17 February 2004
| Drug | Countries | |
|---|---|---|
| CILOXAN | Austria, Australia, Brazil, Canada, Cyprus, Estonia, France, Croatia, Ireland, Israel, Lithuania, Malta, New Zealand, Poland, Singapore, Tunisia, Turkey, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
